GlassScriptPhysician profile
Brandon M Bowers
NPI 1386828515
$21,925.51
in general payments reported to CMS, 2019-2025
47 companies · $5,474 in 2025
The $5,474 reported for 2025 was more than what 89% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,038 · 2020: $1,033 · 2021: $645 · 2022: $1,122 · 2023: $1,868 · 2024: $8,745 · 2025: $5,474.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,822 · Travel and Lodging: $5,560 · Education: $4,698 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,821.65 |
| Travel and Lodging | $5,559.58 |
| Education | $4,697.52 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $11,656.97 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,810.97 | 2019-2025 | Fasenra, Tezspire, Airsupra |
| Veran Medical Technologies, INC. | $1,207.20 | 2019 | |
| Glaxosmithkline, LLC. | $996.75 | 2019-2025 | Trelegy Ellipta, Nucala |
| Regeneron Healthcare Solutions, INC. | $852.54 | 2021-2025 | Dupixent |
| Grifols USA, LLC | $660.34 | 2019-2025 | Prolastin-C Liquid |
| Boehringer Ingelheim Pharmaceuticals, INC. | $431.77 | 2019-2024 | Ofev, Stiolto Respimat |
| Genentech USA, INC. | $379.04 | 2019-2024 | Xolair |
| Sunovion Pharmaceuticals INC. | $355.05 | 2019-2020 | |
| Insmed, INC. | $339.96 | 2019-2025 | Arikayce, Brinsupri |
| Galvanize Therapeutics, INC | $289.90 | 2025 | Aliya System |
| Merck Sharp & Dohme LLC | $284.91 | 2019-2025 | Zerbaxa, Recarbrio |
| Actelion Pharmaceuticals US, INC. | $253.07 | 2019-2025 | Uptravi, Opsynvi, Opsumit |
| Mallinckrodt Hospital Products INC. | $231.75 | 2022-2023 | Acthar |
| Abbvie INC. | $208.73 | 2021-2025 | Avycaz, Dalvance, Teflaro |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Advanced Respiratory, INC | $186.27 | 2019-2020 | |
| Genzyme Corporation | $185.68 | 2019-2024 | |
| Amgen INC. | $158.43 | 2022-2023 | Tezspire |
| Novartis Pharmaceuticals Corporation | $141.00 | 2020-2025 | |
| Teva Pharmaceuticals USA, INC. | $131.21 | 2019-2022 | |
| Vapotherm INC | $123.46 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $121.25 | 2021-2024 | Glassia |
| Mylan Specialty L.P. | $114.38 | 2019-2024 | Yupelri, Perforomist |
| Philips North America LLC | $93.99 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $87.31 | 2020-2021 | |
| Mallinckrodt Enterprises LLC | $78.80 | 2019 | |
| Baxter Healthcare | $68.17 | 2024-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Vest System Model 205 Acute Care |
| Sanofi-Aventis U.S. LLC | $57.48 | 2024 | |
| Electromed, INC. | $56.01 | 2019-2024 | Smartvest |
| Portola Pharmaceuticals, LLC | $31.86 | 2019 | |
| Sanofi Pasteur INC. | $30.56 | 2019-2020 | |
| Radius Health, INC. | $26.90 | 2023 | Tymlos |
| Shire North American Group INC | $23.77 | 2019 | |
| Resmed Corp | $22.67 | 2024 | |
| La Jolla Pharmaceutical Company | $22.45 | 2021 | |
| Jazz Pharmaceuticals INC. | $21.85 | 2020 | |
| Inogen, INC. | $21.22 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Covidien LP | $21.03 | 2019 | |
| Hill-Rom Company, INC | $19.63 | 2021 | |
| Lilly USA, LLC | $19.04 | 2025 | Zepbound, Mounjaro |
| Paratek Pharmaceuticals, INC. | $18.74 | 2023 | Nuzyra |
| Pulmonx Corporation | $17.48 | 2025 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Covis Pharma Gmbh | $17.15 | 2022 | |
| Horizon Therapeutics Plc | $14.31 | 2020 | |
| Neurelis, INC. | $13.69 | 2021 | |
| Fisher & Paykel Healthcare INC | $12.66 | 2019 | |
| Itamar Medical INC | $8.11 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Bowers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.